Petros Pharmaceuticals Inc (PTPI) — Strategic Asset Allocation Index
Petros Pharmaceuticals Inc (PTPI) has a Strategic Asset Allocation Index of 0.2% as of September 2022. Strategic assets (PP&E of $41.73K plus long-term investments of $-) total $41.73K, measured against net assets of $20.69 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Petros Pharmaceuticals Inc net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Petros Pharmaceuticals Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Petros Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2022, the index stands at 0.2%, representing strategic assets of $41.73K against net assets of $20.69 Million USD. For live market cap and overall valuation, see market cap of Petros Pharmaceuticals Inc.
Annual Strategic Asset Allocation Index for Petros Pharmaceuticals Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Petros Pharmaceuticals Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See PTPI net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 2.4% | $397.65K | $397.65K | $- | $16.70 Million | ▲ +0.9 pp |
| 2021 | 1.5% | $524.95K | $524.95K | $- | $35.54 Million | ▼ -2.2 pp |
| 2020 | 3.7% | $643.78K | $643.78K | $- | $17.47 Million | ▼ -5.6 pp |
| 2019 | 9.3% | $742.08K | $742.08K | $- | $8.02 Million | — |